The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HSIC | +3.56% | +16.59% | +3.11% | +1,513% |
| S&P | +12.65% | +91.73% | +13.89% | +1,039% |
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $3.34B | 5.2% |
| Gross Profit | $958.00M | 3.1% |
| Gross Margin | 28.69% | -0.6% |
| Market Cap | $8.05B | -12.9% |
| Market Cap / Employee | $0.32M | 0.0% |
| Employees | 25K | 0.0% |
| Net Income | $109.00M | 10.1% |
| EBITDA | $286.00M | 2.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $136.00M | 7.9% |
| Accounts Receivable | $1.74B | 5.0% |
| Inventory | 1.9K | 9.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.42B | 11.5% |
| Short Term Debt | $1.02B | 24.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.60% | 0.5% |
| Return On Invested Capital | 9.82% | -1.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $141.00M | 20.5% |
| Operating Free Cash Flow | $174.00M | 15.2% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 23.07 | 21.33 | 23.56 | 20.87 | -30.39% |
| Price to Book | 2.47 | 2.51 | 2.70 | 2.35 | -9.84% |
| Price to Sales | 0.70 | 0.68 | 0.70 | 0.62 | -16.97% |
| Price to Tangible Book Value | -5.47 | -5.61 | -5.33 | -4.81 | -16.50% |
| Price to Free Cash Flow TTM | 12.64 | 15.58 | 23.71 | 19.84 | -1.68% |
| Enterprise Value to EBITDA | 48.65 | 47.54 | 54.39 | 44.89 | -8.15% |
| Free Cash Flow Yield | 7.9% | 6.4% | 4.2% | 5.0% | 1.71% |
| Return on Equity | 11.1% | 11.8% | 11.2% | 11.4% | 29.78% |
| Total Debt | $2.87B | $3.22B | $3.36B | $3.44B | 15.01% |
No podcast episodes available.
HSIC earnings call for the period ending June 30, 2022.
HSIC earnings call for the period ending March 31, 2022.
HSIC earnings call for the period ending December 31, 2021.
HSIC earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
